Clinical Study Data Request Registered Users, Please Login

Scroll down the list of studies provided below. Studies are listed by study medicine in alphabetical order. Alternatively you can browse the list of studies using the search function.

To select studies and submit a research proposal or enquiry, go back to the Home page and select View and submit.

This takes you back to the previous page to enable you to view studies from a different sponsor.

Select medicine, medical condition or phase from the drop down boxes. This searches all the available clinical studies. Selecting from more than one drop down box will “and” the criteria.

Find by:


Alternatively search for studies using the Daiichi Sankyo Clinical Study Identification Number or study title by entering text and clicking search.

 

16 found

Click the study title to find more information about the study.

DS-DU-176b PRT007
Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement

Medicine: Edoxaban, Condition: Arthroplasty, Replacement, Hip;   Thrombosis, Phase: 2, Clinical Study ID: DU-176b PRT007, Sponsor: Daiichi Sankyo
DS-DU-176b PRT011
A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery

Medicine: Edoxaban, Condition: Thrombosis;   Hip Replacement, Phase: 2, Clinical Study ID: DU-176b PRT011, Sponsor: Daiichi Sankyo
DS-DU-176b PRT018
A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation

Medicine: Edoxaban, Condition: Atrial Fibrillation;   Thromboembolism, Phase: 2, Clinical Study ID: DU-176b PRT018, Sponsor: Daiichi Sankyo
DS-DU-176b-B-J209
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

Medicine: Edoxaban, Condition: Venous Thromboembolism;   Thromboembolism;   Thrombosis;   Embolism and Thrombosis;   Deep Vein Thrombosis;   Arthroplasty, Replacement, Hip, Phase: 2, Clinical Study ID: DU-176b-B-J209, Sponsor: Daiichi Sankyo
DS-DU-176b-B-J302
A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

Medicine: Edoxaban, Condition: Venous Thromboembolism, Phase: 3, Clinical Study ID: DU-176b-B-J302, Sponsor: Daiichi Sankyo
DS-DU-176b-B-J303
Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery

Medicine: Edoxaban, Condition: Venous Thromboembolism, Phase: 3, Clinical Study ID: DU-176b-B-J303, Sponsor: Daiichi Sankyo
DS-DU-176b-B-J304
A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

Medicine: Edoxaban, Condition: Venous Thromboembolism, Phase: 3, Clinical Study ID: DU-176b-B-J304, Sponsor: Daiichi Sankyo
DS-DU176b-B-J306
Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs

Medicine: Edoxaban, Condition: Venous Thromboembolism, Phase: 3, Clinical Study ID: DU176b-B-J306, Sponsor: Daiichi Sankyo
DS-DU176b-C-J225
Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial Fibrillation

Medicine: Edoxaban, Condition: Atrial Fibrillation, Phase: 2, Clinical Study ID: DU176b-C-J225, Sponsor: Daiichi Sankyo
DS-DU176b-C-J226
DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation

Medicine: Edoxaban, Condition: Atrial Fibrillation;   Stroke, Phase: 2, Clinical Study ID: DU176b-C-J226, Sponsor: Daiichi Sankyo
First Previous 1 2 Next Last